Nectar Lifesciences Limited (NECLIFE) — Board Meeting | 15 August 2026
Nectar Lifesciences announced a board-approved change of its corporate office from Chandigarh's Plot 110 to Godrej Eternia, West Wing (Tower A), Plot 70, effective September 15, 2026, to support operational expansion and strategic growth initiatives.
About Nectar Lifesciences Limited (NECLIFE)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when NECLIFE files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NECLIFE — Free💡 Ask AI about this filing
📊 More NECLIFE filings
- Announcement — 24 September 2026Nectar Lifesciences announced that its trading window closes on October 1, 2026, and remains shut un...
- 🟡 Board Meeting — 19 September 2026Nectar Lifesciences held its 31st AGM on September 18, 2026, approving the 2025-26 standalone financ...
- 🟡 Voting Results — 18 September 2026Nectar Lifesciences shareholders approved all five AGM resolutions, including adoption of FY2026 sta...
- 🟡 Board Meeting — 18 September 2026At the 31st AGM on September 18, 2026, Nectar Lifesciences adopted FY2025-26 standalone and consolid...
- 🔴 Annual Report — 22 August 2026Nectar Lifesciences announced the 2025-26 Annual Report and upcoming AGM on September 18, 2026, acce...
🔥 Also filed on 15 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when NECLIFE files new disclosures
Track NECLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NECLIFE — FreeFree account · 2 AI queries/day